Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy President, Chief Exec Officer bought 100,000 shares at $0.49 ($49,000)
  3. 4 Shares withheld for taxes Chief Medical Officer gave up 3,292 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP, Chief Scientific Officer gave up 3,913 shares (to pay taxes)
  5. 4 Grant or award President, Chief Exec Officer acquired 1,405,000 shares (grant or award)
  6. 4 Grant or award SVP, Chief Scientific Officer acquired 406,000 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 406,000 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 406,000 shares (grant or award)
  9. 4 Grant or award SVP, General Counsel acquired 406,000 shares (grant or award)
  10. 4 Shares withheld for taxes SVP, General Counsel gave up 8,050 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Medical Officer gave up 10,039 shares (to pay taxes)
  12. 4 Shares withheld for taxes President, Chief Exec Officer gave up 22,362 shares (to pay taxes)
  13. 4 Shares withheld for taxes SVP, Chief Scientific Officer gave up 8,050 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 8,050 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP, Chief Scientific Officer gave up 9,242 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Medical Officer gave up 7,964 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, General Counsel gave up 9,242 shares (to pay taxes)
  18. 4 Grant or award Director acquired 32,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 6,132 shares (to pay taxes)

Page 3 of 28 · 550 filings